FNBT
ALBO

FineMark National Bank & Trust’s Albireo Pharma Inc ALBO Stock Holding History

FineMark National Bank & Trust’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-243
Closed -$2K – 1443
2016
Q2 		$2K Buy
+243
New +$2.68K ﹤0.01% 1235

Other funds holding ALBO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
PVH
Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

FineMark National Bank & Trust's ALBO Position: Q3 2016 in Review

FineMark National Bank & Trust sold out of Albireo Pharma Inc (ALBO) in Q3 2016, closing a stake of 243 shares — an estimated $2K sold.

FineMark National Bank & Trust first reported a position in ALBO in Q2 2016 and held it in 1 quarter. The position peaked at $2K in Q2 2016. 22 funds tracked by Wall St. Rank hold ALBO as of Q3 2016.

  • FineMark National Bank & Trust reported no remaining Albireo Pharma Inc position as of Q3 2016 after selling out during the quarter.
  • FineMark National Bank & Trust sold 243 Albireo Pharma Inc shares in Q3 2016, an estimated $2K.
  • FineMark National Bank & Trust first reported a position in Albireo Pharma Inc in Q2 2016 and held it in 1 quarter.
  • FineMark National Bank & Trust's Albireo Pharma Inc position peaked at $2K in Q2 2016.
  • 22 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q3 2016.

Based on FineMark National Bank & Trust's 13F filing for Q3 2016, filed 10 Nov 2016.